Answers are grounded in this paper and cite their sources.
Background Enrolling and retaining participants in randomised trials remains a perpetual challenge, contributing to substantial research waste. While low-certainty evidence suggests that monetary incentives such as vouchers may improve recruitment and retention, synthesising the views of key stakeholders (including trial participants and staff) could reveal critical barriers and facilitators to implementing them in practice. This review therefore aimed to explore the attitudes and experiences of different trial stakeholders regarding the use of monetary incentives for recruiting and retaining trial participants. Methods We conducted a qualitative evidence synthesis (QES) using thematic synthesis. The CINAHL, MEDLINE, Embase, EconLit, and ORRCA databases were searched. We included qualitative or mixed-method studies exploring monetary incentives for recruiting or retaining trial participants in non-Phase I trials in high-income countries. Only studies drawing upon actual trial experiences were included, and we purposively sampled identified studies based on their conceptual richness and alignment with the aims of this QES. Results We included 29 studies involving 862 individuals in our synthesis. Studies primarily captured trial participants’ perspectives, with fewer exploring the perspectives of trial staff. Findings fell into four overarching themes: (1) monetary incentives as a reason for trial participation, (2) the varied purposes served by monetary incentives, (3) ethical and trial integrity concerns, and (4) implementation considerations. Monetary incentives were found to be an important motivator for some (but not all) trial participants. They were seen as serving multiple purposes, namely acknowledging participants’ time and effort, boosting recruitment and retention, and offsetting financial burdens of trial participation. However, stakeholders raised some ethical and trial integrity concerns, such as individuals participating solely for financial gain. Finally, the findings provided practical insights into optimal incentive design, including appropriate value, conditional timing, and delivery formats. Conclusions This review demonstrates that there is no “one-size-fits-all” approach to monetary incentives. Trial teams should co-design incentive structures with Patient and Public Involvement (PPI) partners early in trial design, clearly distinguishing incentives from expense reimbursements. Trial registration PROSPERO CRD420251082475. Registered on 23 July 2025.
No takes yet. Share an insight, caveat, or question.
Mongelli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: